12.01.2013 Views

Manual de Hipertensión Arterial en la Práctica Clínica de ... - SAMFyC

Manual de Hipertensión Arterial en la Práctica Clínica de ... - SAMFyC

Manual de Hipertensión Arterial en la Práctica Clínica de ... - SAMFyC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Manual</strong> <strong>de</strong> <strong>Hipert<strong>en</strong>sión</strong> <strong>Arterial</strong> <strong>en</strong> <strong>la</strong> <strong>Práctica</strong> <strong>Clínica</strong> <strong>de</strong> At<strong>en</strong>ción Primaria<br />

Tratami<strong>en</strong>to Farmacológico<br />

6. Blood Pressure Lowering Treatm<strong>en</strong>t Trialists´ Col<strong>la</strong>boration. Effect of ACE inhibitors, calcium<br />

antagonists, and other blood-pressure-lowering drugs: results of prospectively <strong>de</strong>signed overviews<br />

of randomised trial. Lancet 2000;355:1955-64.<br />

7. Staess<strong>en</strong> JA, Wang JG, Thijs L. Cardiovascu<strong>la</strong>r protection and blood pressure reduction: a metaanalysis.<br />

Lancet 2001;358:1305-15.<br />

8. Blood Pressure Low ering Treatm <strong>en</strong>t Trialists’ Col<strong>la</strong>boration. Effects of differ<strong>en</strong>t blood-pressurelowering<br />

regim<strong>en</strong>s on major cardiovascu<strong>la</strong>r ev<strong>en</strong>ts: results of prospectively-<strong>de</strong>signed overviews of<br />

randomised trials. Lancet 2003; 362: 1527-35.<br />

9. Staess<strong>en</strong> JA, Wang JG, Thijs L. Cardiovascu<strong>la</strong>r prev<strong>en</strong>tion and blood pressure reduction: a<br />

quantitative overview updated until 1 March 2003. J Hypert<strong>en</strong>s 2003; 21: 1055-76.<br />

10. Chobanian AV, Bakris GL, B<strong>la</strong>ck HR, Cushman WC, Gre<strong>en</strong> LA, Izzo JL Jr, et al. The sev<strong>en</strong>th report of<br />

the Joint National Committee on Prev<strong>en</strong>tion, Detection, Evaluation and Treatm<strong>en</strong>t of High Blood<br />

Pressure: the JNC 7 report. JAMA 2003;289:2560-72.<br />

11. Chobanian AV, Bakris GL, B<strong>la</strong>ck HR, Cushman WC, Gre<strong>en</strong> LA, Izzo JL Jr, et al. Sev<strong>en</strong>th report of the<br />

Joint National Committee on Prev<strong>en</strong>tion, Detection, Evaluation and Treatm<strong>en</strong>t of High Blood<br />

Pressure. JNC 7 – Complete version. Hypert<strong>en</strong>sion 2003;42:1206-52.<br />

12. Khan NA, McAlister FA, Lewanczuk RZ, Touvz RM, Padwal R, Rabkin SW, et al. The 2005 Canadian<br />

<strong>Hipert<strong>en</strong>sión</strong> Education Program recom<strong>en</strong>dations for the managem<strong>en</strong>t of hypert<strong>en</strong>sion: part II<br />

therapy. Can J Cardiol 2005;21(8):657-72<br />

13. World Health Organization, International Society of Hypert<strong>en</strong>sion writing group. 2003 World<br />

Health Organization (WHO) / International Society of Hypert<strong>en</strong>sion (ISH) statem<strong>en</strong>t on<br />

managem<strong>en</strong>t of hypert<strong>en</strong>sion. J Hypert<strong>en</strong>s 2003;21:1983-92.<br />

14. Gui<strong>de</strong>lines Committee. 2003 European Society of Hypert<strong>en</strong>sion – European Society of Cardiology<br />

gui<strong>de</strong>lines for the managem<strong>en</strong>t of arterial hypert<strong>en</strong>sion. J Hypert<strong>en</strong>s 2003:21:1011-53.<br />

15. De Backer G, Ambrosioni E, Borch-Johs<strong>en</strong> K, Brotons C, Cifkova R, Dallongeville J, et al. Third Joint<br />

Task Force of European and other Societies on Cardiovascu<strong>la</strong>r Disease Prev<strong>en</strong>tion in Clinical<br />

Practice. Executive summary. European gui<strong>de</strong>lines on cardiovascu<strong>la</strong>r disease prev<strong>en</strong>tion in clinical<br />

practice. Eur Heart J 2003;24:1601-10.<br />

16. Comité Español Interdisciplinario para <strong>la</strong> Prev<strong>en</strong>ción Cardiovascu<strong>la</strong>r (CEIPC), Brotons C, Royo-<br />

Bordonada MA, Álvarez-Sa<strong>la</strong> L, Armario P, Artigao R, Conthe P, et al. Adaptación españo<strong>la</strong> <strong>de</strong> <strong>la</strong><br />

Guía Europea <strong>de</strong> Prev<strong>en</strong>ción Cardiovascu<strong>la</strong>r. At<strong>en</strong> Primaria 2004;34:427-32.<br />

17. Wexler R, Feldman D. Hypert<strong>en</strong>sion: Which drugs to choose for pati<strong>en</strong>ts with cardiovascu<strong>la</strong>r<br />

disease. J Fam Practice 2006;55(4):291-98.<br />

18. Alcázar JM. Tratami<strong>en</strong>to <strong>de</strong> <strong>la</strong> hipert<strong>en</strong>sión arterial. En: Hernando L, Aljama P, Arias M, Caramelo<br />

C, Egido J, Lamas S, eds. Nefrología <strong>Clínica</strong>. Madrid: Editorial Médica Panamericana S.A. 2003;210-<br />

218.<br />

Grupo <strong>de</strong> <strong>Hipert<strong>en</strong>sión</strong> <strong>Arterial</strong><br />

Sociedad Andaluza <strong>de</strong> Medicina <strong>de</strong> Familia<br />

78

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!